期刊文献+

HSV1-tk 报告基因真核表达载体的构建及其在人肺腺癌 AGZY 细胞中的表达 被引量:1

Construction and expression of HSV1-tk eukaryotic vector in lung adenocarcinoma AGZY cell line
暂未订购
导出
摘要 目的:构建含有HSV1-tk( Herpes simplex virus type 1 thymidine kinase, HSV1-tk)基因的真核表达载体,并检测其在人肺腺癌AGZY细胞系中的表达。方法应用PCR反应从质粒pHSV106质粒中扩增HSV1-tk基因后与pMD18-T载体连接,构建重组质粒pHSV1-tk/18T。将测序正确的重组质粒插入plRES2-EGFP 载体内,通过LipofectamineTM 2000将表达载体转染人肺腺癌AGZY细胞。结果酶切鉴定结果表明扩增的HSV1-tk基因序列正确;用荧光显微镜观察HSV1-tk基因的转入和表达;RT-PCR和Western blot结果显示在AGZY细胞中HSV1-tk基因在转录水平和蛋白水平均可以正确表达。MTT结果显示转染后AGZY细胞与未转染细胞在细胞增殖能力方面无明显差别。结论成功构建HSV1-tk报告基因的真核表达载体,在人肺腺癌AGZY细胞中能有效表达。 Objective The purpose of this study is to construct eukaryotic gene vector of herpes simplex virus type 1 thymidine kinase(HSV1-tk)and to observe the expression of HSV1-tk in lung adenocarcinoma AGZY cell line.Methods The full length HSV1-tk gene was amplified by PCR from plasmid pHSV 106 and was inserted into pMD18-T.The recombinant plasmid was recombined with eukaryotic vector plRES 2-EGFP u-sing gene recombinant technique .HSV1 -tk was transfected into adenocarcinoma AGZY cell line with Lipo-fectamineTM 2 000.Fluorescence microscopy was used to detect the transfection and expression of HSV 1-tk.RT-PCR was used to detect the mRNA levels of HSV 1-tk.The cell proliferation was measured by MTT assay .Re-sults A length of 1 130 bp gene sequence was obtained by PCR .The expressions of HSV 1-tk at mRNA and protein levels were displayed by RT -PCR and Western blot .MTT analysis showed that there were no significant changes cell survival on after transfection .Conclusion The eukaryotic expression vector of HSV 1 -tk report gene is successfully constructed and HSV 1-tk is effectively expressed in transfected AGZY cells .
出处 《实用肿瘤学杂志》 CAS 2014年第2期97-101,共5页 Practical Oncology Journal
基金 国家自然科学基金(81171362) 黑龙江省自然科学基金(D201060)
关键词 HSV1-TK 真核表达载体 报告基因显像 肺腺癌AGZY细胞 Herpes simplex virus type 1 thymidine kinase Eukaryotic expression vector Reporter geneimaging Lung adenocarcinoma AGZY cell
  • 相关文献

参考文献13

  • 1Cao S, Cripps A, Wei MQ. New strategies for cancer gene therapy: progress and opportunities [ J [ Clin Exp Pharmacol Physiol,2010,37( 1 ) :108 - 114.
  • 2Ahn H, Choi TH, De CK, et al. Synthesis and evaluation of els - 1 - [ 4 - (hydroxymethyl) - 2 - eyelopenten - 1 - yl ] - 5 - [ (124) I] iodouraeil:a new potential PET imaging a- gent for HSVl - tk expression [ J ]. J Med Chem, 2007,50 (24) :6032 -6038.
  • 3Chin FT, Namavari M, Levi J, et al. Semiautomated radio- synthesis and biolngieal evaluation of [ 18F ] FEAU:a novel PET imaging agent for HSVl -tk/sr39tk reporter gene ex- pression[J]. Mol Imaging Biol,2008,10(2) :82 -91.
  • 4于雁,孙凤林,陈雪松.自杀基因HSV-TK对肺癌细胞增殖活性影响的实验研究[J].实用肿瘤学杂志,2005,19(1):11-13. 被引量:2
  • 5钱伟峰,黄宗海,赵玲美.HSVtk/GCV系统体外杀伤大肠癌LoVo细胞的实验研究[J].实用肿瘤学杂志,2003,17(1):24-26. 被引量:2
  • 6苏君,杨海城,肖宏,张学新.自杀基因HSV-TK/ACV系统对人脑胶质瘤细胞DNA含量的影响[J].实用肿瘤学杂志,2002,16(2):104-106. 被引量:1
  • 7Likar Y, Dobrenkov K, Olszewska M, et al. A new acy- cloguanosine - specific supermutant of herpes simplex virus type 1 thymidine kinase suitable for PET imaging and sui- cide gene therapy for potential use in patients treated with pyrimidine - based cytotoxic drugs [ J ]. J Nucl Med,2008, 49(5) :713 -720.
  • 8Johnson M, Karanikolas BD, Priceman SJ, et al. Titration of variant HSV1 - tk gene expression to determine the sensitiv- ity of 18F- FHBG PET imaging in a prostate tumor[J]. J Nuel Meal,2009,50 (5) :757 - 764.
  • 9Moohen FL. Tumor chemosensifivity conferred by inserted herpes thymidine kinase genes:paradigm for a prospective cancer control strategy [ J ]. Cancer Res, 1986,46 ( 10 ) : 5276 - 5281.
  • 10Yaghoubi SS,Wu L, Liang Q,et al. Direct correlation be- tween positron emission tomographie images of two reporter genes delivered by two distinct adenoviral vectors [ J ]. Gene Therapy,2001,8 (14) : 1072 - 1080.

二级参考文献35

  • 1张学斌,张冠军,杨兆瑞,张兵林.胆囊粘膜增生、异型增生和癌细胞核的DNA、AgNOR含量测定研究[J].陕西医学杂志,1996,25(4):238-241. 被引量:2
  • 2黄进 周晓军 张泰和 等.AgNOR染色影响因素探讨.临床与实验病理杂志[J],1996,6:229-231.
  • 3Bianchi S, Palierani M, Zampi G, et al. Prognostic value of proliferating cell nuclear antigen in lymph node-negative breast cancer patients [J]. Cancer [J], 1993; 72:120~125.
  • 4Matheus RS, Bernardi Fdel C, Gallo CP. Nuclear markers (star volume, mitotic index, AgNOR and Ki-67) of the primary tumor and its metastasis in non-small cell lung carcinomas. Pathol Res Pract [J], 2004;200(1):13~23.
  • 5Barwijuk-Machala M, Musiatowicz B, Cylwik J, AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features. Folia Morphol (Warsz), 2004;63(1):133~5.
  • 6许良中.关于核仁组成区研究工作的标准方案[J].中华肿瘤杂志,1996,18:69-69.
  • 7William P, The role of interleukin-1 receptor antagonist in the prevention and treatment of disease. Mod Rheumatol, 2003, 13: 1-6.
  • 8Mao XQ, Kawai M, Yamashita T, Enomoto T, Dake Y, Sasaki S, Imbalance production between interleukin- 1b (IL-1b) and IL-1 receptor antagonist (IL-1ra) in bronchial asthma. Biochem Biophys Res Commun, 2000, 276: 607-612.
  • 9Schmitz N, Kurrer M & Kopf M, The IL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur J Immunol, 2003, 33: 991-1000.
  • 10Dinarello CA, Interleukin-1 and Interleukin-1 antagonism. Blood, 1991, 77(8): 1 627-1552.

共引文献5

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部